Kolexia
Gilabert Marine Oncologie médicale
Gilabert Marine
Oncologie médicale
Centre Paoli-Calmettes
Marseille, France
160 Activités
563 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Tumeurs du pancréas Carcinome du canal pancréatique Métastase tumorale Carcinomes Carcinome hépatocellulaire Tumeurs du sein Tumeurs du foie Tumeurs colorectales

Collaborateurs

Voir plus
Turrini Olivier
Turrini Olivier
Centre Paoli-Calmettes, Marseille, France
Raoul Jean-Luc
Raoul Jean-Luc
Institut de cancérologie de l'Ouest, Saint-Herblain, France
Delpero Jean-Robert
Delpero Jean-Robert
Centre Paoli-Calmettes, Marseille, France
Ewald Jacques
Ewald Jacques
Centre Paoli-Calmettes, Marseille, France

Industries

Voir plus
B3TSI
4 collaboration(s)
Dernière en 2021
Servier
4 collaboration(s)
Dernière en 2020
CanceroDigest
3 collaboration(s)
Dernière en 2021
A+A
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
Management and outcomes of brain metastases from pancreatic adenocarcinoma: a pooled analysis and literature review.
Frontiers in oncology   08 janvier 2024
TEDOPAM: A Randomized Non-comparative Phase II Study of Maintenance Therapy With OSE2101 Plus FOLFIRI, or FOLFIRI After Induction Therapy With FOLFIRINOX in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (TEDOPaM-D17-01 PRODIGE 63 Study)
Essai Clinique (Ose Immunotherapeutics)   24 février 2023
Drug-drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure.
ESMO open   08 février 2023
Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study.
British journal of cancer   14 mai 2022
Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC): Immunostimulating Interstitial Laser Thermotherapy in Patients With Locally Advanced Pancreatic Cancer: Results of a Prospective, Open, Non Comparative Study
Essai Clinique (Clinical Laserthermia Systems AB)   19 avril 2022
Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper.
Cancers   24 février 2022
2021 Oncology update.
Revue medicale suisse   04 février 2022
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study.
British journal of cancer   29 janvier 2022
OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients.
BMC cancer   06 janvier 2022